The medication, called N-propargylglycine (N-PPG), blocks an enzyme that triggers excess oxalate production, the main culprit behind PH2.
In mouse studies, those given N-PPG had fewer kidney stones and healthier kidneys than untreated mice.
While more research is needed before it's available for people, this breakthrough could make life a lot easier for those living with PH2.